Dr. Doug Humber: Cardiology

Research Summary: Cardiology

Dr. Humber is currently a faculty preceptor at UCSD’s Sulpizio Cardiovascular Center teaching pharmacy students and residents in both the acute and ambulatory care setting. His primary research interests include investigations into novel antiplatelet therapies utilizing genetic and point-of-care testing to characterize or predict cardiovascular endpoints. Other research interests include examinations into the management of acute coronary syndromes, new and emerging antithrombotic agents, and investigations into the prevention and treatment of venous thromboembolism. Dr. Humber joined the faculty at UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences in July 2011.

Academic Achievements

Education: B.A. Pharmacology, (1992); University of California, Santa Barbara; Pharm.D., University of California, San Francisco (1996); ASHP 2-year Pharmacy Practice Residency, University of California, San Diego Medical Center (1998); UCSD Healthcare Supervisor’s Academy (2007).

Awards and Honors: Preceptor of the Year Award, UCSD Pharmacy Practice Residency Program (2002); Volunteer Faculty Member of the Year Award, SSPPS Associated Student Body (2007).

Leadership Experience: Director, PGY2 Pharmacy Residency in Critical Care, UCSD Pharmacy Department (2004-2009); Chair, Anticoagulation Committee, UCSD Medical Center (2006-2011); Chair, Clinical Council, UCSD Pharmacy Department (2008-2011); Chair, Emergency Department and Pharmacy Taskforce, UCSD Medical Center (2009-2011).

Teaching

• Ischemic Heart Disease / Acute MI, Heart Failure, and Arrhythmias (SPPS 212B)
• Co-chair Pharmacy Therapeutics (SPPS 212B)
• APPE Acute Care – Cardiology (SPPS 400 A/B)
• APPE Ambulatory Care – Advanced Heart Failure Treatment Program (SPPS 401 A/B)

Key Contributions to Clinical Pharmacy

• Solidified the role of the pharmacist on a multidisciplinary ST-Elevation-MI response team at UCSD Medical Center.
• Streamlined abciximab and eptifibatide dosing protocols and co-developed an algorithm for the use of tenecteplase for ST-Elevation-MI patients at UCSD Medical Center.
• Co-developed factor IX treatment guidelines for the Electrophysiology Lab when performing on- warfarin catheter ablations at UCSD Medical Center.
• Developed UCSD Medical Center treatment algorithms for the safe use of dofetilide.
• Co-developed and implemented protocols for the use of therapeutic heparin and warfarin at UCSD Medical Center.

Selected Recent Publications

Humber and Jahansouz (2007). Clinical pharmacology review. In, Wilson WC, Grande CM, Hoyt DB, eds. Trauma: critical care, volume 2; New York. CRC Press.

Humber et al. (2010). Anticoagulation in the Cardiology Patient. Audio-Digest – Emergency Medicine. May 21, 2010:27(10). ISSN 0748-8947

Maynard G, et.al. (2011). Optimizing Inpatient Anticoagulation: Strategies for Quality Improvement. In: Fang M, editor. Inpatient Anticoagulation. Wiley-Blackwell. [Forthcoming]

Potential Collaborative Programs with the Pharmaceutical Industry

• 13 years of clinical pharmacy experience with an emphasis in cardiology, anticoagulation, and critical care
• Examinations into the management of acute coronary syndromes
• Investigations into antiplatelet and antithrombotic medicines utilizing genetic and point-of-care testing to characterize or predict cardiovascular endpoints